Heron Therapeutics Statistics

Total Valuation

HRTX has a market cap or net worth of $228.25 million. The enterprise value is $322.26 million.

Market Cap	228.25M
Enterprise Value	322.26M

Important Dates

The next confirmed earnings date is Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

HRTX has 188.64 million shares outstanding. The number of shares has increased by 9.35% in one year.

Current Share Class	188.64M
Shares Outstanding	188.64M
Shares Change (YoY)	+9.35%
Shares Change (QoQ)	+10.38%
Owned by Insiders (%)	0.76%
Owned by Institutions (%)	55.29%
Float	133.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.47
Forward PS	1.28
PB Ratio	17.15
P/TBV Ratio	17.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 9.81.

Current Ratio	2.48
Quick Ratio	1.42
Debt / Equity	9.81
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.26

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-0.65%
Return on Invested Capital (ROIC)	-1.06%
Return on Capital Employed (ROCE)	-1.59%
Weighted Average Cost of Capital (WACC)	9.53%
Revenue Per Employee	$1.21M
Profits Per Employee	-$157,773
Employee Count	128
Asset Turnover	0.63
Inventory Turnover	0.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.39% in the last 52 weeks. The beta is 1.42, so HRTX's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-47.39%
50-Day Moving Average	0.97
200-Day Moving Average	1.26
Relative Strength Index (RSI)	73.29
Average Volume (20 Days)	1,997,858

Short Selling Information

The latest short interest is 41.15 million, so 21.81% of the outstanding shares have been sold short.

Short Interest	41.15M
Short Previous Month	39.42M
Short % of Shares Out	21.81%
Short % of Float	30.77%
Short Ratio (days to cover)	21.77

Income Statement

In the last 12 months, HRTX had revenue of $154.90 million and -$20.20 million in losses. Loss per share was -$0.12.

Revenue	154.90M
Gross Profit	112.52M
Operating Income	-2.54M
Pretax Income	-20.20M
Net Income	-20.20M
EBITDA	-224,000
EBIT	-2.54M
Loss Per Share	-$0.12

Full Income Statement

Balance Sheet

The company has $46.63 million in cash and $140.64 million in debt, giving a net cash position of -$94.01 million or -$0.50 per share.

Cash & Cash Equivalents	46.63M
Total Debt	140.64M
Net Cash	-94.01M
Net Cash Per Share	-$0.50
Equity (Book Value)	14.33M
Book Value Per Share	0.07
Working Capital	141.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.59 million and capital expenditures -$317,000, giving a free cash flow of -$27.91 million.

Operating Cash Flow	-27.59M
Capital Expenditures	-317,000
Depreciation & Amortization	2.31M
Net Borrowing	-12.76M
Free Cash Flow	-27.91M
FCF Per Share	-$0.15

Full Cash Flow Statement

Margins

Gross margin is 72.64%, with operating and profit margins of -1.64% and -13.04%.

Gross Margin	72.64%
Operating Margin	-1.64%
Pretax Margin	-13.04%
Profit Margin	-13.04%
EBITDA Margin	-0.14%
EBIT Margin	-1.64%
FCF Margin	n/a

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.35%
Shareholder Yield	-9.35%
Earnings Yield	-8.85%
FCF Yield	-12.23%

Analyst Forecast

The average price target for HRTX is $4.50, which is 271.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	271.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	16.70%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 13, 2014
Split Type	Reverse
Split Ratio	1:20

Scores

HRTX has an Altman Z-Score of -8.7 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.7
Piotroski F-Score	4